Left Ventricular Diastolic Dysfunction Clinical Trial
Official title:
Assessment of the Possible Association Between Left Ventricular Diastolic Dysfunction and Carotid Atherosclerosis and Brain White Matter Damage
Left ventricular diastolic dysfunction is caused by impaired relaxation and increased left ventricular stiffness with a consequent increase in filling pressures. Currently, it is possible to classify it in 3 grades: grade 1 with normal filling pressures, grade 2 and grade 3 with high pressures. Diastolic dysfunction is closely associated with several risk factors such as hypertension, diabetes, and obesity, as well as the risk of heart failure, cardiovascular events, and death. In the field of cerebrovascular diseases, however, diastolic dysfunction is still being researched. Thus, this study aims to: 1) evaluate the white matter hyperintensities volume in association with the increase of diastolic dysfunction and filling pressures 2) evaluate the possible association with carotid atherosclerosis in case of brain damage caused by dysfunction diastolic 3) understand the mechanism of damage caused by left ventricular diastolic dysfunction on the cerebrovascular system. In order to do this, this study proposes to evaluate in a cohort of patients, between 35 and 65 years, the possible association of diastolic dysfunction with lesions on the cerebrovascular system in a future view of new marker of brain damage and new modifiable risk factor.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01888796 -
Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus
|
Phase 3 | |
Active, not recruiting |
NCT03962166 -
Characterizing Patients With POAF in Relation to Cardiac Surgery by wavECG and TTE
|
||
Completed |
NCT04154878 -
2 New Measurements Used to Describe the Filling Phase of the Left Ventricle (LV).
|
||
Recruiting |
NCT01747187 -
Cardiac Stress in Septic Shock - Biomarkers, Echocardiography and Outcome
|
N/A | |
Completed |
NCT02251431 -
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome
|
Phase 3 | |
Completed |
NCT04699565 -
Characterization of Patients With Post-ischemic Left Ventricular Dysfunction
|
||
Recruiting |
NCT04752293 -
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
|
||
Completed |
NCT01961323 -
Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart
|
Phase 4 | |
Completed |
NCT00405548 -
Human Brain Natriuretic Peptide (BNP) (or Nesiritide) to Help Heart, Kidney and Humoral Function.
|
Phase 1/Phase 2 | |
Recruiting |
NCT04433533 -
Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia
|
Phase 4 | |
Recruiting |
NCT03534037 -
Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction
|
Phase 4 | |
Active, not recruiting |
NCT04687111 -
Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
|
Phase 2 | |
Completed |
NCT04505449 -
Invasive Left Heart Catheterization Registry
|
||
Not yet recruiting |
NCT06431919 -
Carvedilol + Simvastatin vs. Carvedilol Alone for Chronic Liver Disease and Cirrhotic Cardiomyopathy and Its Impact on Hepatic Decompensation and Survival; a Double-blind Randomized Controlled Trial
|
N/A | |
Completed |
NCT04703387 -
Left Ventricular Diastolic Dysfunction as a Predictor of Weaning Failure From Mechanical Ventilation
|
||
Terminated |
NCT03495999 -
Hyperuricemia and Left Ventricular Diastolic Function
|
||
Completed |
NCT03522194 -
Left Ventricular Diastolic Function During Anesthesia Induction
|